Finasteride and Anxiety: Evidence & Guidance
Medically reviewed by [Reviewer Name, MD] | Last reviewed: August 2026 | Editorial policy
Bottom line: Anxiety and mood changes have been reported by some finasteride users and are listed as post-marketing adverse events in the FDA prescribing information (updated 2012). A biologically plausible mechanism exists via neuroactive steroid pathways. However, large randomized trials did not identify anxiety as a statistically significant adverse event vs. placebo, and the absolute risk at the individual level remains uncertain.
The Neuroactive Steroid Mechanism
5-alpha-reductase converts progesterone to allopregnanolone in the brain — a potent positive allosteric modulator of GABA-A receptors. GABA-A activation is the primary mechanism of anxiolytic (anti-anxiety) signaling in the CNS. By inhibiting 5-AR throughout the body — including the brain — finasteride reduces allopregnanolone production, potentially shifting the GABAergic balance toward a more anxiogenic (pro-anxiety) state in susceptible individuals.
Animal studies confirm finasteride reduces brain allopregnanolone. Human data are more limited but support this mechanism at the pharmacological level. Whether the magnitude of this reduction is clinically significant at the 1 mg dose in most men is not established.
What Clinical Trials Found
The Phase III Propecia trials (1998) did not measure anxiety with validated psychometric instruments and did not identify anxiety as an adverse event occurring at significantly different rates than placebo. Post-marketing reports and patient registries (including PFS Foundation data) document anxiety among the most commonly reported persistent symptoms after discontinuation. The causal attribution and prevalence are difficult to establish from self-reported registries.
What to Do if You Experience Anxiety
- Report new or worsening anxiety to your prescribing physician promptly
- Do not self-discontinue without medical guidance — abrupt stopping does not guarantee immediate resolution and your provider should monitor the transition
- Rule out other causes: concurrent stressors, sleep disruption, caffeine, thyroid dysfunction, and other medications
- If anxiety resolves after stopping finasteride, discuss with your provider whether the relationship was causal
See: Side effects overview | Finasteride and depression | Brain fog | Post-Finasteride Syndrome